Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR.

Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to ...

Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR. Todd Plott, M.D., Chief Medical Officer, Epiphany Dermatology will join Robert ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into ...

Researchers have found a way to make cancer-killing immune cells more powerful and precise. By adding specific signaling components, they boosted the cells’ readiness to attack tumors. Surprisingly, ...

Keytruda drug is approved for a wide range of solid tumors and blood cancers, often for cases that are advanced, metastatic ...

A new update from the (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma ...

By Sneha S K April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse ...

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...

The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

Whereas most of the cells in a healthy animal’s body get along by following the same set of genetic rules, cancer cells ...